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Background/Aims: We aimed to estimate the cumulative 
incidence of advanced colonic neoplasia and analyze the 
risk factors for advanced colonic neoplasia according to risk 
components and adenoma location at index colonoscopy. 
Methods: We reviewed 1,974 subjects who underwent a fol-
low-up colonoscopy after a complete screening colonoscopy 
and the removal of all polyps. We estimated the cumulative 
incidence of a subsequent advanced neoplasia according 
to risk groups (normal, low-risk, and high-risk). Risk factors 
were analyzed by risk components (≥3 adenomas, adenoma 
≥1 cm, and villous-type adenoma) and adenoma location. 
Results: Overall, 111 advanced neoplasias (5.6%) were 
newly diagnosed at the follow-up colonoscopy. The 3-year cu-
mulative incidences of advanced neoplasia were 0.8%, 3.1%, 
and 10.2% in the normal, low-risk, and high-risk groups, re-
spectively (p<0.0001), and the 5-year cumulative incidences 
were 2.2%, 8.6%, and 20.2%, respectively (p<0.0001). Age 
≥60 years (hazard ratio [HR], 1.78; 95% confidence interval 
[CI], 1.21 to 2.63), right-sided colonic adenoma (HR, 1.74; 
95% CI, 1.13 to 2.66), ≥3 adenomas (HR, 2.00; 95% CI, 1.22 
to 3.28), and adenomas ≥1 cm in size (HR, 2.03; 95% CI, 1.20 
to 3.44) in the index colonoscopy were independent risk fac-
tors for subsequent development of advanced neoplasia. 
Conclusions: Right-sided colonic adenoma, ≥3 adenomas, 
adenomas ≥1 cm, and age ≥60 years at the index colonos-
copy were significant risk factors for advanced neoplasia fol-
lowing a complete screening colonoscopy and removal of all 
polyps. (Gut Liver 2017;11:667-673)
Key Words: Colonic neoplasms; Colonoscopy; Early detection 
of cancer 
INTRODUCTION
Colorectal cancer (CRC) is a major cause of mortality.1,2 It is 
the second most commonly diagnosed cancer in Korea, after 
thyroid cancer,3 where it accounts for 17% of newly diagnosed 
cancers.4 Considering that the transition from premalignant to 
malignant status takes 10 to 15 years, early detection of CRC 
is crucial.5 Colonoscopy is associated with lower CRC mortality 
rates6,7 and is a well-established screening modality, recom-
mended for all individuals >50 years old.8 Because the preva-
lence of advanced adenoma and the incidence of CRC increases 
with age, advanced adenomas, implicated in the etiology of 
colon cancer, are a significant concern for the average-risk in-
dividual.
For the Korean population, one prospective study reported 
that the 3- and 5-year incidence of advanced adenoma recur-
rence after polypectomy in high-risk patients was 9.6% and 
12.2%, respectively.9 The presence of ≥3 adenomas and an 
adenoma size ≥1 cm were independent predictors for recurrent 
advanced colorectal neoplasia.9 Two recent retrospective stud-
ies reported that age is a significant risk factor for developing 
colorectal neoplasms after removal of high-risk adenomas,10 and 
that the presence of multiple high-risk findings was associated 
with an increased risk of advanced neoplasia during surveil-
lance.11
The aims of this study were to determine the cumulative 
incidence of advanced neoplasia at follow-up colonoscopy in 
subjects who had undergone complete screening colonoscopy 
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and removal of all polyps, and to identify the risk factors for 
advanced neoplasia according to risk components and adenoma 
location at index colonoscopy in asymptomatic subjects. We 
analyzed subsequent advanced neoplasia by risk components (≥3 
adenomas, adenoma size ≥1 cm, and villous-type adenoma) and 
adenoma location at index colonoscopy.
MATERIALS AND METHODS
1. Study subjects
A total of 11,930 subjects underwent cancer screening colo-
noscopy at the Health Promotion Center of Gangnam Sever-
ance Hospital between July 2007 and January 2012. Of these, 
we excluded those with baseline CRC; nonneoplastic polyps, 
such as hyperplastic or inflammatory polyps; those whose colo-
noscopy was incomplete; and subjects who did not undergo 
follow-up colonoscopy. Thus, we retrospectively analyzed 1,974 
outpatients. For 1,588 of the 1,974 subjects (80.4%), the index 
colonoscopy was their first colonoscopy, whereas 225 subjects 
(11.4%) had undergone colonoscopy previously, and 161 (8.2%) 
had an unknown colonoscopy history. All 225 subjects with 
previous colonoscopy reported no significant findings (such as 
colon cancer) or colonic surgery. Polyps and adenomas detected 
during colonoscopy were removed by standard biopsy using 
forceps or by polypectomy. All colonoscopies were performed 
by six board-certified endoscopists, each of whom had per-
formed >3,000 colonoscopies and had an adenoma detection 
rate of >25% for routine procedures.8
Subjects were grouped according to risk, based on the index 
colonoscopy findings, as follows: a high-risk group, subjects 
with advanced adenoma or ≥3 adenomas; a low-risk group, 
those with 1 to 2 adenomas <1 cm in size; and a normal group, 
subjects with no colonic polyps (of any kind) at index colo-
noscopy. The cumulative incidence of advanced neoplasia at 
follow-up colonoscopy was determined stratified by risk group. 
The study was approved by the Yonsei University Gangnam 
Severance Hospital’s Institutional Review Board (approval num-
ber: 3-2015-0040).
2. Variables and definitions
Colonic neoplasias were histopathologically confirmed as be-
ing either adenomas or adenocarcinomas. Advanced adenoma 
was defined as a lesion ≥1 cm in diameter, a lesion with vil-
lous or tubulovillous histologic characteristics, or a lesion with 
high-grade dysplasia.12 Advanced neoplasia was defined as 
advanced adenoma or adenocarcinoma. Synchronous adenomas 
were evaluated and the size of the largest one was used in the 
analysis. The size of the adenomas was estimated using biopsy 
forceps. Right-sided colonic adenomas were defined as those 
occurring in the portion of the colon proximal to the splenic 
Table 1. Comparison of Baseline Characteristics among Subjects Who Underwent a Follow-up Colonoscopy
Characteristic
Overall
 (n=1,974)
Normal group  
(n=574)
Low-risk group 
(n=1,050)
High-risk group 
(n=350)
p-value
Age, yr 55.7±7.1 53.3±6.4 56.1±6.8 58.3±7.6 <0.0001
Male sex 1,423 (72.1) 379 (66.0)  768 (73.1) 276 (78.9) <0.0001
Follow-up duration, mo 41.8±21.7 49.5±23.7 38.9±20.1 37.7±19.6 <0.0001
2 Or more adenomas 572 (29.0) - 279 (26.6) 293 (83.7) <0.0001
Advanced adenoma 201 (10.2) - - 201 (57.4)
Age group, yr <0.0001
    40–59 1,438 (72.9) 475 (82.8) 753 (71.7) 210 (60.0)
    60–69  439 (22.2)  86 (15.0) 241 (23.0) 112 (32.0)
    ≥70  97 (4.9) 13 (2.2) 56 (5.3) 28 (8.0)
Adenoma location <0.0001
    Right-sided only 542 (27.5) - 475 (45.2) 67 (19.1)
    Left-sided only 549 (27.8) - 466 (44.4) 83 (23.7)
    Both RT and LT 309 (15.7) - 109 (10.4) 200 (57.2)
Villous component  69 (3.5) - - 69 (19.7)
Adenoma ≥1 cm 182 (9.2) - - 182 (52.0)
≥3 Adenomas 239 (12.1) - - 239 (68.3)
Current smoking 320 (16.2) 71 (12.4) 175 (16.7)  74 (21.1) 0.002
Family history of colorectal cancer 79 (4.0) 20 (3.5) 46 (4.4)  13 (3.7) 0.648
Withdrawal time, min 7.9±5.0 4.6±2.4 8.3±3.6 12.2±5.8 <0.001
Data are presented as mean±SD or number (%).
RT, right side of the colon; LT, left side of the colon.
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flexure. Colonic adenoma location was identified as left-sided 
only, right-sided only, and both right- and left-sided; right-
sided adenomas comprised the latter two locations. 
The following variables were analyzed for each patient: sex; 
age; laboratory results; and the number, size, location, and his-
tology results of adenomas found and removed. The results of 
the fecal occult blood test (FOBT) and body mass index (BMI) 
were obtained from the medical records. BMI was dichotomized 
as ≥25 kg/m2 and <25 kg/m2 for the analysis. Age was catego-
rized as <60 years and ≥60 years. 
3. Statistical analysis
Characteristics of colonic neoplasia such as the size, loca-
tion, pathology, and laboratory findings were compared using 
t-tests for continuous variables and chi-square tests for cat-
egorical variables. Continuous variables are presented as the 
mean±standard deviation (SD). We have presented the univari-
able and multiple regression models that included the relevant 
variables. For all comparisons, two-sided p-values <0.05 were 
considered statistically significant, and 95% confidence intervals 
(CI) are given. The Kaplan-Meier method was used to describe 
the cumulative incidence of advanced neoplasia. Cox regres-
sion analysis was used to determine the hazard ratio (HR) of 
advanced neoplasia at follow-up colonoscopy according to rel-
evant variables. Analyses were performed using the R Statistical 
Package version 3.1.2 (Institute for Statistics and Mathematics, 
Vienna, Austria; http://www.R-project.org) and SAS statistical 
software version 9.2 (SAS Institute Inc., Cary, NC, USA).
RESULTS
1. Characterization of colonic neoplasia at index screening 
colonoscopy
The baseline characteristics of the 1,974 subjects are listed 
in Table 1. At baseline, the subjects’ mean age was 55.7±7.1 
years, and 72.1% were male. Overall, 1,400 subjects (70.9%) had 
colonic adenomas; 572 (29.0%) had ≥2 colonic adenomas, and 
201 (10.2%) had advanced adenomas. There were 350 (17.7%), 
1,050 (53.2%), and 574 (29.1%) subjects in the high-risk, low-
risk, and normal group, respectively. In terms of age, 1,438 sub-
jects (72.8%) were aged 40 to 59 years; 439 (22.2%) were aged 
60 to 69 years; and 97 (4.9%) were aged ≥70 years. Right-sided 
colonic adenomas were seen in 851 of subjects overall (43.1%), 
and in 60.8% of the 1,400 subjects with colonic adenomas. 
Sixty-nine subjects (3.5%) had villous histology, 182 (9.2%) had 
adenomas ≥1 cm in size, and 239 (12.1%) had ≥3 adenomas. 
Of the 1,400 subjects with adenomas, 43 (3.07%) had serrated 
adenomas/polyps. In the low-risk group, 17 subjects (1.6%) had 
serrated adenomas, whereas 26 subjects (7.4%) in the high-risk 
group had serrated adenomas. 
2. Advanced colonic neoplasia at follow-up colonoscopy
The mean follow-up period was 41.8±21.7 months. Overall, 
111 subjects were diagnosed with advanced neoplasia (5.6%) 
Table 2. Summary of the Six Patients with Newly Diagnosed Colonic Adenocarcinoma at Follow-up Colonoscopy 
No Age/sex
Risk  
group
Withdrawal 
time, min
Interval,  
mo*
Adenocarcinoma location, size,  
type in follow-up colonoscopy
TNM stage Treatment
1 68/M Low   8 23.9 Ascending colon, 1.2 cm, 
LST NG type
pT1N0M0
Adenocarcinoma, well 
differentiated
(Laparoscopic)
Right hemicolectomy
2 58/M Low   8 12.0 Ascending colon, 2.5 cm, 
LST NG type
pTis
Adenocarcinoma, well 
differentiated
Endoscopic submucosal 
dissection
3 60/M Low 13 35.7 Sigmoid colon, 2.5 cm, 
ulcerofungating
pT3N1M0
Adenocarcinoma, moderately 
differentiated
(Laparoscopic)
Low anterior resection
4 73/M High† 14 29.7 Transverse colon, 1.0 cm, 
LST NG type
pTis
Adenocarcinoma, well 
differentiated
Endoscopic submucosal 
dissection
5 57/M High 15 68.8 Ascending colon, 3.0 cm, 
ulcero-infiltrative
pT3N2aM1
Mucinous adenocarcinoma
Extended right hemicolectomy
Right adrenalectomy
6 70/M Normal <6 54.2 Transverse colon, 1.0 cm, 
ulcerative
pT1N0M0
Adenocarcinoma, well 
differentiated
(Laparoscopic)
Transverse colectomy
TNM stage, depth of invasion: submucosa (pT1), subserosa (pT3), adenocarcinoma in situ (pTis).
M, male; LST NG, laterally spreading tumor, nongranular.
*Months between the index screening colonoscopy and follow-up colonoscopy at which cancer was detected; †Polypectomy in the index colonoscopy 
with pathology-proven complete resection of the adenoma.
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during follow-up colonoscopy (after having undergone com-
plete screening and removal of all polyps at the index colonos-
copy). Of these, 58 subjects (52.3%) had ≥3 adenomas, 96 (86.5%) 
had lesions ≥1 cm in size, and 23 adenomas (20.7%) had villous 
histology. No significant difference in the location of these 
advanced neoplasms was observed between the right- (n=69, 
62.2%) and left-sided (n=42, 37.8%) colon (p=0.219). 
Six subjects were newly diagnosed with adenocarcinomas 
during follow-up colonoscopy (Table 2): one from the normal 
group, three from the low-risk group, and two from the high-
risk group. All six adenocarcinomas were located in different 
sites from where adenomas were removed at the index colo-
noscopy; five were located in the right-sided colon (one in the 
sigmoid colon, two in the transverse colon, and three in the 
ascending colon). Two cases were treated with endoscopic sub-
mucosal dissection (both had adenocarcinoma in situ [pTis]); 
the others were treated surgically (two cases had submucosal 
[pT1] invasion and two cases had subserosal [pT3] invasion). 
One subject had metastases to the adrenal gland. After adjuvant 
chemotherapy, an extended right hemicolectomy with right ad-
renalectomy was performed. The final pathology was mucinous 
adenocarcinoma with serosal invasion. 
3. Cumulative incidence of advanced neoplasia at follow-up 
colonoscopy
Incidence of advanced neoplasia at the follow-up colonos-
copy according to risk group are listed in Table 3. The 3-year 
cumulative incidences of advanced neoplasia stratified by risk 
group were as follows: high-risk group, 10.2% (95% CI, 0.86 
to 0.94); low-risk group 3.1% (95% CI, 0.96 to 0.98); normal 
group 0.8% (95% CI, 0.98 to 1.00) (p<0.0001). The correspond-
ing 5-year cumulative incidences of advanced neoplasia were 
20.2% (95% CI, 0.74 to 0.87); 8.6% (95% CI, 0.89 to 0.94); and 
2.2% (95% CI, 0.96 to 0.99), respectively (p<0.0001) (Fig. 1). The 
3-year cumulative incidence of advanced neoplasia stratified by 
age group was 40 to 59 years, 2.6% (95% CI, 0.96 to 0.98); 60 
to 69 years, 4.6% (95% CI, 0.93 to 0.98); and ≥70 years, 10.0% 
(95% CI, 0.84 to 0.97) (p<0.0001). The corresponding 5-year 
cumulative incidences were 6.7% (95% CI, 0.91 to 0.95); 10.0% 
(95% CI, 0.86 to 0.94); and 19.4% (95% CI, 0.70 to 0.92), respec-
tively (p<0.0001). Age ≥60 years, current smoking, FOBT posi-
tivity, right-sided colonic adenoma at index colonoscopy, low-
risk group (vs normal), high-risk group (vs normal) and high-
risk components (≥3 adenomas, adenoma ≥1 cm in size, villous 
type) were risk factors for subsequent advanced neoplasia in the 
univariable analysis.
In the multivariable analysis, age ≥60 years (vs <60 years: 
HR, 1.78; 95% CI, 1.21 to 2.63), right-sided colonic adenomas (vs 
non-right-sided colonic adenomas: HR, 1.74; 95% CI, 1.13 to 
2.66), ≥3 adenomas (vs no adenomas ≥3: HR, 2.00; 95% CI, 1.22 
to 3.28), and adenoma ≥1 cm in size (vs no adenoma ≥1 cm: 
HR, 2.03; 95% CI, 1.20 to 3.44) at index colonoscopy were inde-
pendent risk factors for recurrent advanced neoplasia at follow-
up (Table 4).
DISCUSSION
The incidence of CRC in Korea is increasing. The annual per-
centage change in age-standardized incidence rates between 
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Fig. 1. Cumulative incidence of recurrent advanced neoplasia ac-
cording to risk group at the index colonoscopy. The 3-year cumula-
tive incidence of advanced neoplasia in each risk group was 10.2% 
in the high-risk group (advanced neoplasia or ≥3 adenomas; 95% 
confidence interval [CI], 0.86–0.94), 3.1% in the low-risk group (1–2 
adenomas <1 cm in size; 95% CI, 0.96–0.98), and 0.8% in the nor-
mal group (95% CI, 0.98–1.00) (p<0.0001). The 5-year cumulative 
incidence of advanced neoplasia in each risk group was 20.2% in the 
high-risk group (95% CI, 0.74–0.87), 8.6% in the low-risk group (95% 
CI, 0.89–0.94), and 2.2% in the normal group (95% CI, 0.96–0.99) 
(p<0.0001).
Table 3. Incidence of Advanced Neoplasia at Follow-up Colonoscopy According to Risk Group (p<0.0001)
Follow-up  
duration, mo
Normal group (n=574) Low-risk group (n= 1,050) High-risk group (n=350)
No.  
risk
Cumulative  
incidence rate (%)
95% CI
No.  
risk
Cumulative  
incidence rate (%)
95% CI
No.  
risk
Cumulative  
incidence rate (%)
95% CI
36 367 0.8 0.984–1.000 543 3.1 0.957–0.982 179 10.2 0.861–0.936
48 322 1.4 0.975–0.997 374 5.2 0.930–0.967 102 15.7 0.793–0.895
60 238 2.2 0.962–0.994 187 8.6 0.885–0.944   61 20.2 0.736–0.866
72 188 2.7 0.954–0.992   80 12.2 0.834–0.925   23 28.7 0.612–0.830
No. risk, numbers of subjects at risk; CI, confidence interval.
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1999 and 2009 was +6.2%.3 The age-standardized mortality 
rates of CRC continue to increase, unlike those of other common 
cancers whose mortality rates have decreased in recent years.13 
The prevalence of colorectal neoplasms in Korean individuals 
aged 50 to 59 years was 30.1% for overall neoplasia and 6.7% 
for advanced neoplasia.14 In this study, the proportion of sub-
jects with adenomas increased significantly with age. Notably, a 
previous study reported that increasing age was associated with 
a higher prevalence of right-sided lesions.14
According to the Korean guidelines for postpolypectomy 
colonoscopic surveillance, patients should be considered at high 
risk for subsequent advanced neoplasia at surveillance colonos-
copy when one or more of the following conditions have been 
detected at index colonoscopy: (1) 3 or more adenomas, (2) any 
adenoma larger than 10 mm, (3) any tubulovillous or villous 
adenoma, (4) any adenoma with high-grade dysplasia, and (5) 
any serrated polyps larger than 10 mm.15 Adenomas located in 
the right side of the colon at index colonoscopy are of concern 
but not confirmed. 
Two recent retrospective studies reported that age was a sig-
nificant risk factor for developing colorectal neoplasms after 
removal of high-risk adenomas,10 and that the presence of mul-
tiple high-risk findings was associated with an increased risk 
of advanced neoplasia during surveillance.11 Concurring with 
the findings of a retrospective study conducted by the Intestinal 
Cancer Study Group of the Korean Association for the Study 
of Intestinal Diseases,10 we also found that in the multivariate 
analysis, age ≥60 years was a significant risk factor for ad-
Table 4. Relative Risks of Advanced Neoplasia at the Follow-up Colonoscopy According to the Characteristics at the Index Colonoscopy
Characteristic
Univariable analysis Multivariable analysis 
HR (95% CI) p-value HR (95% CI) p-value
Age, yr
    <60 1 1
    ≥60 2.090 (1.4436–3.043) 0.0001 1.781 (1.208–2.625) 0.004
Sex
    Female 1 1
    Male 1.156 (0.744–1.794) 0.519 0.854 (0.536–1.359) 0.505
Family history of colorectal cancer
    No 1 1
    Yes 1.356 (0.553–3.325) 0.506 1.521 (0.610–3.796) 0.369
Current smoking 
    No 1 1
    Yes 1.592 (1.019–2.486) 0.041 1.451 (0.897–2.347) 0.129
BMI ≥25 kg/m2
    No 1 1
    Yes 1.101 (0.745–1.626) 0.629 1.082 (0.728–1.608) 0.698
Stool occult blood test positivity
    No 1 1
    Yes 2.040 (1.094–3.806) 0.025 1.205 (0.610–2.381) 0.591
Right-sided colonic adenoma at index colonoscopy
    No 1 1
    Yes 2.646 (1.803–3.883) <0.0001 1.736 (1.131–2.664) 0.012
Risk groups
    Normal 1
    Low-risk 3.391 (1.867–6.161) <0.0001
    High risk 9.103 (4.966–16.686) <0.0001
High-risk component
    ≥3 Adenomas (vs no adenomas ≥3) 3.880 (2.576–5.844) <0.0001 2.000 (1.218–3.282) 0.006
    Adenoma ≥1 cm (vs no adenoma ≥1 cm) 3.814 (2.469–5.891) <0.0001 2.034 (1.204–3.436) 0.008
    Villous type (vs no villous adenoma) 3.730 (1.999–6.961) <0.0001 1.130 (0.544–2.348) 0.743
HR, hazard ratio; CI, confidence interval; BMI, body mass index.
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vanced colorectal neoplasia following complete screening colo-
noscopy with removal of all polyps.
Chung et al.9 reported in a prospective study that the 5-year 
and 3-year incidence of advanced adenoma among high-risk 
patients was 12.2% and 9.6%, respectively, after adenoma re-
moval. In the present study, the 5-year and 3-year incidence of 
advanced neoplasia at follow-up colonoscopy in the high-risk 
group was 20.2% and 10.2%, respectively. Follow-up colonos-
copy at 3 years is recommended for patients with any of the 
following: ≥3 adenomas, a tubular adenoma ≥1 cm in size, a 
villous adenoma ≥1 cm in size, and an adenoma with high-
grade dysplasia.16 In the Asia Pacific Consensus, a risk-stratified 
scoring system is recommended for selecting factors indicating 
high-risk for CRC and advanced neoplasia.17 The scoring system 
includes age (50 to 69 years vs ≥70 years), male sex, having a 
first-degree relative with CRC, and current or past smoking.17 
Low-risk is defined as having 0 to 1 criterion; intermediate-risk, 
2 to 3 criteria; and high-risk, 4 to 7 criteria.17 In this study, after 
adjustment for age, sex, family history of CRC, smoking, BMI 
>25 kg/m2, FOBT positivity, ≥3 adenomas, adenoma ≥1 cm in 
size, villous component, and adenoma location, the following 
factors at index colonoscopy were significant risk factors for 
advanced neoplasia at follow-up colonoscopy: age ≥60 years, 
≥3 adenomas, adenoma ≥1 cm in size, and any right-sided co-
lonic adenoma. Although the presence of right-sided colonic 
adenomas at index colonoscopy was not considered as a high 
risk condition for subsequent advanced neoplasia at surveillance 
colonoscopy, the trend toward a greater number of adenomas 
missed in the right-side colon compared with the left was of 
concern.18 
In the subanalysis, right-sided only colonic adenomas were 
significant in the multivariable analysis (Supplementary Table 1). 
Age ≥60 years, right-sided only colonic adenoma, ≥3 adenomas, 
and adenoma ≥1 cm in size were also significant risk factors 
for advanced adenoma at follow-up colonoscopy. Hence, we 
presented that any right-sided colonic adenoma is significant 
for subsequent advanced neoplasia. However, no significant dif-
ference in the location of subsequent advanced neoplasia was 
observed between the right- (62.2%) and left-sided colon (37.8%) 
(p=0.219). At index colonoscopy, right-sided only adenoma was 
seen in 45.2% of subjects in the low-risk group and in 19.1% of 
subjects in the high-risk group, while both right- and left-sided 
adenomas were seen in 10.4% and 57.2% of subjects in the 
low-risk and high-risk group, respectively. This difference at in-
dex colonoscopy could affect the outcome. Otherwise, bacterial 
biofilms are associated with CRC and microbiota organization 
is a distinct feature of proximal CRCs;19 the location of baseline 
adenomas could be a risk factor for advanced colonic neoplasia, 
but further studies are needed. 
There were six (male) subjects who had adenocarcinomas 
diagnosed at follow-up colonoscopy. These adenocarcinomas 
were located in the right-sided colon in five of the six subjects 
(83%). 
There are several possible reasons for these six subsequent co-
lonic cancers detected at follow-up colonoscopy. First, it is pos-
sible that lesions were missed at the index colonoscopy. Right-
sided sessile serrated adenomas or spreading-type advanced 
lesions are easy to miss. In these six patients, ulcerative type 
(n=1), ulcero-infiltrative type (n=1), ulcero-fungating type (n=1), 
and laterally spreading tumor nongranular type (n=3) was tu-
mors were seen, these lesions could have been missed at index 
colonoscopy. Second, incomplete resection of a lesion is pos-
sible. At index colonoscopy, four cases were treated with biopsy 
removal and one with polypectomy. Even though complete re-
section was reported in the polypectomy case, a remnant lesion 
at the biopsy site could be the reason for interval cancer. Third, 
new lesions or rapid progression is possible. A CIMP (CpG island 
methylator phenotype)-high/BRAF (B-type Raf kinase) muta-
tion or microsatellite instability could result in rapid progression 
of cancer after dysplasia, or a sessile-serrated adenoma/polyp 
could be a precursor of interval cancer. Sessile-serrated adeno-
mas/polyps are more prevalent in the right-sided colon. More-
over, 83% of follow-up colon cancers were right-sided in this 
study. Last, inappropriate withdrawal time at index colonoscopy 
is a possible reason for interval cancer. The withdrawal time of 
618 index colonoscopies (31.3%) was <6 minutes (colonoscopy 
procedure time: mean±SD, 13.5±6.2 minutes; withdrawal time: 
mean±SD, 7.9±5.0 minutes). A withdrawal time of <6 minutes 
was mostly noted from 2007 to 2009 (85.9%). 
The current study had several limitations. It was retrospective 
and conducted at a single center; it was not population based. 
It included individuals who underwent regular health exami-
nations, which could have introduced selection bias and the 
potential for incomplete data. Follow-up duration also varied. 
We could not measure other confounders, such as food intake 
and consumption. Those who underwent screening were funded 
by employers (60%) or were self-funded (40%), and may have 
been more health conscious than the general population.20 The 
incidence of lesions, chance of missed lesions, or incomplete 
removal at initial screening colonoscopy was possible.21 The 
Boston Bowel Preparation Scale was applied for assessment 
of the quality of bowel preparation in 2011; prior to that, data 
were subjectively categorized by the endoscopist as “excellent,” 
“good,” “fair,” and “poor.” Although subjects with “excellent,” 
“good” and “fair” bowel preparation were analyzed, these terms 
lacked standardized definitions. Nevertheless, considering the 
emerging interest in interval colon cancer in patients, advanced 
neoplasia at follow-up colonoscopy according to risk group, 
risk components and baseline adenoma location was useful 
in furthering the understanding of advanced neoplasia in the 
average-risk individual. 
In conclusion, the 3-year cumulative incidence of advanced 
neoplasia by risk group was 10.2%, 3.1%, and 0.8% in the high-
risk, low-risk, and normal group, respectively. The correspond-
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ing 5-year cumulative incidences were 20.2%, 8.6%, and 2.2%, 
respectively. In terms of high-risk components, ≥3 adenomas, 
adenomas ≥1 cm, any right-sided colonic adenoma, and age 
≥60 years at index colonoscopy were significant risk factors for 
advanced neoplasia at follow-up colonoscopy. Further studies 
are needed for adenoma location, especially right-sided colonic 
location, and subsequent advanced neoplasia.
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